Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marwa Hassan Shukr & Omar A. Ahmed Farid. (2021) Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion. Pharmaceutical Development and Technology 26:4, pages 464-475.
Read now
Read now
Silvia Cerri & Fabio Blandini. (2020) An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease. Expert Opinion on Pharmacotherapy 21:18, pages 2279-2291.
Read now
Read now
Chandrakantsing V. Pardeshi & Veena S Belgamwar. (2020) Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs. Materials Technology 35:5, pages 249-266.
Read now
Read now
Saleha Rehman, Bushra Nabi, Ameeduzzafar Zafar, Sanjula Baboota & Javed Ali. (2019) Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?. Expert Opinion on Drug Delivery 16:12, pages 1355-1366.
Read now
Read now
Yongjun Jiang, Yun Li & Xinfeng Liu. (2015) Intranasal delivery: circumventing the iron curtain to treat neurological disorders. Expert Opinion on Drug Delivery 12:11, pages 1717-1725.
Read now
Read now
Articles from other publishers (30)
Muhammad Ahsan Waqar, Muhammad Zaman, Huma Hameed, Muhammad Jamshaid, Ali Irfan, Gamal A. Shazly, Ana Cláudia Paiva-Santos & Yousef A. Bin Jardan. (2023) Formulation, Characterization, and Evaluation of β-Cyclodextrin Functionalized Hypericin Loaded Nanocarriers. ACS Omega 8:41, pages 38191-38203.
Crossref
Crossref
Shobhit Kumar, Satish Kumar Gupta & Rakesh Pahwa. (2023) Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism. Journal of Psychiatric Research 165, pages 205-218.
Crossref
Crossref
Mohammad, Urooj Ahmed Khan, Zoya Saifi, Jinku Bora, Musarrat Husain Warsi, Mohammed A. S. Abourehab, Gaurav Kumar Jain, Prashant Kesharwani & Asgar Ali. (2023) Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism. Inflammopharmacology.
Crossref
Crossref
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 358, pages 293-318.
Crossref
Crossref
Vanshita Singh, Akash Garg, Rajeev Sharma & Hitesh Kumar Dewangan. (2023) Recent Advances of Nanotechnology in Brain Targeting. Current Nanoscience 19:3, pages 350-361.
Crossref
Crossref
Sara Meirinho, Márcio Rodrigues, Catarina L. Ferreira, Rui Caetano Oliveira, Ana Fortuna, Adriana O. Santos, Amílcar Falcão & Gilberto Alves. (2022) Intranasal delivery of lipid-based nanosystems as a promising approach for brain targeting of the new-generation antiepileptic drug perampanel. International Journal of Pharmaceutics 622, pages 121853.
Crossref
Crossref
Chhavi Bhalothia & Girima Nagda. (2022) Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 69, pages A1-A13.
Crossref
Crossref
Rahul Shukla, Vaibhavi Srivastava, Aakriti Sethi & Munindra Ruwali. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
243
259
.
Vildan Seyhan, Samet Özdemir, Aslı Barla Demirkoz & Melike Üner. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
33
.
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Crossref
Sara Silva, António Almeida & Nuno Vale. (2021) Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 13:4, pages 508.
Crossref
Crossref
Muhammad Usama Ashhar, Shobhit Kumar, Javed Ali & Sanjula Baboota. (2021) CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect. Chemistry and Physics of Lipids 235, pages 105035.
Crossref
Crossref
Nida Nehal, Bushra Nabi, Saleha Rehman, Ankita Pathak, Ashif Iqubal, Saif Ahmad Khan, M. Shahar Yar, Suhel Parvez, Sanjula Baboota & Javed Ali. (2021) Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment. International Journal of Biological Macromolecules 167, pages 605-619.
Crossref
Crossref
Shiv Bahadur, Dinesh M. Pardhi, Jarkko Rautio, Jessica M. Rosenholm & Kamla Pathak. (2020) Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 12:12, pages 1230.
Crossref
Crossref
Ramin Ansari, Seyed Mahdi Sadati, Negin Mozafari, Hajar Ashrafi & Amir Azadi. (2020) Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders. European Polymer Journal 128, pages 109607.
Crossref
Crossref
Aruna Sharma, Dafin F. Muresanu, Ala Nozari, José Vicente Lafuente, Seaab Sahib, Z. Ryan Tian, Anca D. Buzoianu, Ranjana Patnaik, Lars Wiklund & Hari Shanker Sharma. 2020. Neuropharmacology of Neuroprotection. Neuropharmacology of Neuroprotection
157
231
.
Satheeswaran Balasubramanian, Azhwar Raghunath & Ekambaram Perumal. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
713
734
.
Ekta Kadakia, Dean Bottino & Mansoor Amiji. (2019) Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration. Pharmaceutical Research 36:5.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Chandrakantsing V. Pardeshi & Veena S. Belgamwar. (2018) N,N,N‑trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery. International Journal of Biological Macromolecules 120, pages 2560-2571.
Crossref
Crossref
Shobhit KumarShweta DangKudeep NigamJaved AliSanjula Baboota. (2018) Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease. Rejuvenation Research 21:5, pages 464-476.
Crossref
Crossref
Nazia Khan, Ameeduzzafar, Kushagra Khanna, Aseem Bhatnagar, Farhan Jalees Ahmad & Asgar Ali. (2018) Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies. International Journal of Biological Macromolecules 116, pages 648-663.
Crossref
Crossref
Bijay Kumar GuptaShobhit KumarHarleen KaurJaved AliSanjula Baboota. (2018)
Attenuation of Oxidative Damage by Coenzyme Q
10
Loaded Nanoemulsion Through Oral Route for the Management of Parkinson's Disease
. Rejuvenation Research 21:3, pages 232-248.
Crossref
Crossref
Md. Faheem Haider, Saba Khan, Bharti Gaba, Tausif Alam, Sanjula Baboota, Javed Ali & Asgar Ali. (2018) Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation. Journal of Molecular Liquids 255, pages 384-396.
Crossref
Crossref
Amrita Nagi, Babar Iqbal, Shobhit Kumar, Shrestha Sharma, Javed Ali & Sanjula Baboota. (2017) Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability. Journal of Drug Delivery Science and Technology 40, pages 35-44.
Crossref
Crossref
Dignesh Khunt, Brijesh Shah & Manju Misra. (2017) Role of butter oil in brain targeted delivery of Quetiapine fumarate microemulsion via intranasal route. Journal of Drug Delivery Science and Technology 40, pages 11-20.
Crossref
Crossref
Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy & Elaine Del-Bel. (2016) Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotoxicity Research 30:4, pages 715-729.
Crossref
Crossref
Shobhit Kumar, Javed Ali & Sanjula Baboota. (2016)
Design Expert
®
supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson’s disease
. Nanotechnology 27:43, pages 435101.
Crossref
Crossref
Yogendra Raj Pandey, Shobhit Kumar, Bijay Kumar Gupta, Javed Ali & Sanjula Baboota. (2016) Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology 27:2, pages 025102.
Crossref
Crossref
Xiao-Yu Xiao, Ying-Xian Zhu, Ju-Yuan Bu, Guo-Wei Li, Jian-Hui Zhou & Shao-Peng Zhou. (2016) Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model. BioMed Research International 2016, pages 1-11.
Crossref
Crossref